US 11401246
Triazole glycolate oxidase inhibitors
granted A61PA61P13/12
Quick answer
US patent 11401246 (Triazole glycolate oxidase inhibitors) held by Century Therapeutics, Inc. expires Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Century Therapeutics, Inc.
- Grant date
- Tue Aug 02 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61P, A61P13/12